5-[[5-[4-(3-fluoroazetidin-3-yl)-2-methoxyphenyl]pyrazolidin-3-yl]amino]pyrazine-2-carbonitrile

C18H20FN7O — CID 146047581

IUPAC5-[[5-[4-(3-fluoroazetidin-3-yl)-2-methoxyphenyl]pyrazolidin-3-yl]amino]pyrazine-2-carbonitrile
SMILESCOc1cc(C2(F)CNC2)ccc1C1CC(Nc2cnc(C#N)cn2)NN1
InChIInChI=1S/C18H20FN7O/c1-27-15-4-11(18(19)9-21-10-18)2-3-13(15)14-5-16(26-25-14)24-17-8-22-12(6-20)7-23-17/h2-4,7-8,14,16,21,25-26H,5,9-10H2,1H3,(H,23,24)
InChIKeyPJIKLWLJRRABGY-UHFFFAOYSA-N
MW369.40 g/mol
LogP1.10
Rot. Bonds5

About 5-[[5-[4-(3-fluoroazetidin-3-yl)-2-methoxyphenyl]pyrazolidin-3-yl]amino]pyrazine-2-carbonitrile

5-[[5-[4-(3-fluoroazetidin-3-yl)-2-methoxyphenyl]pyrazolidin-3-yl]amino]pyrazine-2-carbonitrile (PubChem CID 146047581) has the molecular formula C18H20FN7O and a molecular weight of 369.40 g/mol. Its IUPAC name is 5-[[5-[4-(3-fluoroazetidin-3-yl)-2-methoxyphenyl]pyrazolidin-3-yl]amino]pyrazine-2-carbonitrile.

Molecular Properties

Compound Name5-[[5-[4-(3-fluoroazetidin-3-yl)-2-methoxyphenyl]pyrazolidin-3-yl]amino]pyrazine-2-carbonitrile
PubChem CID146047581
Molecular FormulaC18H20FN7O
Molecular Weight369.40 g/mol
Exact Mass369.17
IUPAC Name5-[[5-[4-(3-fluoroazetidin-3-yl)-2-methoxyphenyl]pyrazolidin-3-yl]amino]pyrazine-2-carbonitrile
SMILESCOc1cc(C2(F)CNC2)ccc1C1CC(Nc2cnc(C#N)cn2)NN1
InChIInChI=1S/C18H20FN7O/c1-27-15-4-11(18(19)9-21-10-18)2-3-13(15)14-5-16(26-25-14)24-17-8-22-12(6-20)7-23-17/h2-4,7-8,14,16,21,25-26H,5,9-10H2,1H3,(H,23,24)
InChIKeyPJIKLWLJRRABGY-UHFFFAOYSA-N
XLogP1.10
TPSA106.92 Ų
H-Bond Donors4
H-Bond Acceptors8
Rotatable Bonds5
Heavy Atoms27
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500369.40
LogP ≤ 51.10
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 108

Analyze 5-[[5-[4-(3-fluoroazetidin-3-yl)-2-methoxyphenyl]pyrazolidin-3-yl]amino]pyrazine-2-carbonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

US10010547, Example 6
CID 146047510
US10010547, Example 7
CID 146047511
US10010547, Example 8
CID 146047512
US10010547, Example 32
CID 146047536
US10010547, Example 58
CID 146047562
US10010547, Example 64
CID 146047568
US10010547, Example 66
CID 146047570
US10010547, Example 76
CID 146047580
US10010547, Example 85
CID 146047589
US10010547, Example 86
CID 146047590
US10010547, Example 87
CID 146047591
US10010547, Example 88
CID 146047592

Frequently Asked Questions

What is the IUPAC name of 5-[[5-[4-(3-fluoroazetidin-3-yl)-2-methoxyphenyl]pyrazolidin-3-yl]amino]pyrazine-2-carbonitrile?
The IUPAC name of 5-[[5-[4-(3-fluoroazetidin-3-yl)-2-methoxyphenyl]pyrazolidin-3-yl]amino]pyrazine-2-carbonitrile (CID 146047581) is 5-[[5-[4-(3-fluoroazetidin-3-yl)-2-methoxyphenyl]pyrazolidin-3-yl]amino]pyrazine-2-carbonitrile.
What is the SMILES notation for 5-[[5-[4-(3-fluoroazetidin-3-yl)-2-methoxyphenyl]pyrazolidin-3-yl]amino]pyrazine-2-carbonitrile?
The canonical SMILES for 5-[[5-[4-(3-fluoroazetidin-3-yl)-2-methoxyphenyl]pyrazolidin-3-yl]amino]pyrazine-2-carbonitrile is COc1cc(C2(F)CNC2)ccc1C1CC(Nc2cnc(C#N)cn2)NN1.
What is the InChIKey of 5-[[5-[4-(3-fluoroazetidin-3-yl)-2-methoxyphenyl]pyrazolidin-3-yl]amino]pyrazine-2-carbonitrile?
The InChIKey is PJIKLWLJRRABGY-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H20FN7O/c1-27-15-4-11(18(19)9-21-10-18)2-3-13(15)14-5-16(26-25-14)24-17-8-22-12(6-20)7-23-17/h2-4,7-8,14,16,21,25-26H,5,9-10H2,1H3,(H,23,24).
What are the key properties of 5-[[5-[4-(3-fluoroazetidin-3-yl)-2-methoxyphenyl]pyrazolidin-3-yl]amino]pyrazine-2-carbonitrile?
5-[[5-[4-(3-fluoroazetidin-3-yl)-2-methoxyphenyl]pyrazolidin-3-yl]amino]pyrazine-2-carbonitrile has a molecular weight of 369.40 g/mol, XLogP of 1.10, 5 rotatable bonds, 4 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[[5-[4-(3-fluoroazetidin-3-yl)-2-methoxyphenyl]pyrazolidin-3-yl]amino]pyrazine-2-carbonitrile is sourced from PubChem (CID 146047581), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).